These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1550609)

  • 1. Drug promotion and scientific exchange.
    Wilbur RS
    N Engl J Med; 1992 Jan; 326(2):133-4. PubMed ID: 1550609
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug promotion and scientific exchange.
    Blue BA
    N Engl J Med; 1992 Jan; 326(2):133; author reply 134. PubMed ID: 1727222
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug promotion and scientific exchange.
    Vogel RM
    N Engl J Med; 1992 Jan; 326(2):134. PubMed ID: 1727224
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug promotion and scientific exchange.
    Blackwell RE
    N Engl J Med; 1992 Jan; 326(2):133; author reply 134. PubMed ID: 1727221
    [No Abstract]   [Full Text] [Related]  

  • 5. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

  • 6. The ethics of pharmaceutical promotion.
    Musher DM; Young EJ; Hamill RJ
    N Engl J Med; 1986 Aug; 315(9):590. PubMed ID: 3736648
    [No Abstract]   [Full Text] [Related]  

  • 7. The regulation of prescription drug advertising.
    Rheinstein RH; Hugstad PS
    Leg Med Annu; 1978; ():407-19. PubMed ID: 756944
    [No Abstract]   [Full Text] [Related]  

  • 8. Sounding Boards. The support of continuing medical education by pharmaceutical companies.
    Kaplan NM
    N Engl J Med; 1979 Jan; 300(4):194-6. PubMed ID: 759847
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ
    Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
    [No Abstract]   [Full Text] [Related]  

  • 10. "A matter of influence": graduate medical education and commercial sponsorship.
    N Engl J Med; 1988 Jan; 318(1):52-4. PubMed ID: 3336386
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical promotions.
    Sobel BJ
    N Engl J Med; 1992 Dec; 327(23):1686; author reply 1688. PubMed ID: 1435905
    [No Abstract]   [Full Text] [Related]  

  • 12. Tarnishing the medical profession's image.
    Sivarajan M
    N Engl J Med; 1985 Apr; 312(17):1132. PubMed ID: 3982477
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical promotions--a free lunch?
    Waud DR
    N Engl J Med; 1992 Jul; 327(5):351-3. PubMed ID: 1620175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?].
    Eckardt VF
    Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharma PR or medical education?
    Rentmeester CA
    Hastings Cent Rep; 2005; 35(2):6. PubMed ID: 15957306
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing influences: an overview.
    Worthen DB
    Br J Med Educ; 1973 Jun; 7(2):109-17. PubMed ID: 4725046
    [No Abstract]   [Full Text] [Related]  

  • 17. Take a meeting. Drug firms hosting many more events for docs.
    Romano M
    Mod Healthc; 2001 Jul; 31(29):9. PubMed ID: 11484239
    [No Abstract]   [Full Text] [Related]  

  • 18. A prescription for better prescriptions.
    Woosley RL
    Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
    [No Abstract]   [Full Text] [Related]  

  • 19. Education or promotion?
    Noble RC
    N Engl J Med; 1992 Jul; 327(5):363-4. PubMed ID: 1620188
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-company influence on medical education in USA.
    Lancet; 2000 Sep; 356(9232):781. PubMed ID: 11022918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.